Peripheral Arteriopathy Rate In Stroke (PARIS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of Erlangen-Nürnberg Medical School
Sponsor:
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier:
NCT00794066
First received: November 18, 2008
Last updated: February 25, 2014
Last verified: February 2014

November 18, 2008
February 25, 2014
August 2008
June 2014   (final data collection date for primary outcome measure)
Functional outcome (modified Rankin Scale) [ Time Frame: 3 months ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT00794066 on ClinicalTrials.gov Archive Site
Prevalence of peripheral arterial disease [ Time Frame: during hospital stay ] [ Designated as safety issue: No ]
Presence or not of PAD as assessed using ABI during hospital stay
Not Provided
Not Provided
Not Provided
 
Peripheral Arteriopathy Rate In Stroke
Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients

Purpose:

To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

Interventions:

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Design:

Prospective, open, cohort study.

Study size planned:

1500.

Follow-up duration:

3 months.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

consecutive patients with acute ischemic or hemorhagic stroke.

Peripheral Artery Disease
Procedure: measuring the ankle brachial index
Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).
  • 1
    TIA
    Intervention: Procedure: measuring the ankle brachial index
  • 2
    Ischemic stroke
    Intervention: Procedure: measuring the ankle brachial index
  • 3
    Hemorrhagic stroke
    Intervention: Procedure: measuring the ankle brachial index
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
1500
December 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All consecutive adult patients with acute ischemic or hemorrhagic stroke.

Exclusion Criteria:

  • Congestive heart failure.
Both
18 Years and older
No
Contact: Hagen B. Huttner, MD +4991318544523 hagen.huttner@uk-erlangen.de
Contact: Martin Köhrmann, MD +4991318544544 martin.koehrmann@uk-erlangen.de
Germany
 
NCT00794066
PARIS-Study2009
No
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg Medical School
Not Provided
Study Director: Stefan Schwab, MD Head of the Department of Neurology, University of Erlangen, Germany
University of Erlangen-Nürnberg Medical School
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP